Abeona Therapeutics ABEO
NASDAQ ABEO
$5.16 -0.13 (-2.46%)
At close: Sep 29, 2026 · 4:00 PM EDT

Abeona Therapeutics (ABEO) Research & Development (2011 - 2026)

Updated

Abeona Therapeutics (ABEO) posted Research & Development of $5.02 million for Q2 2026, down 15.5% from $5.94 million a year earlier and down 47.5% from the prior quarter.

Analysis

Abeona Therapeutics (ABEO) Research & Development (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Research & Development at Abeona Therapeutics was $25.5 million, down 24.6% year-over-year; for FY2025, it came in at $26.81 million, down 22.0% from FY2024.

  • Annual Research & Development shows a five-year compound annual growth rate of -2.3% (FY2020 to FY2025).
  • In prior years, Abeona Therapeutics' Research & Development was $34.36 million in FY2024 (+10.5%), $31.09 million in FY2023 (+7.3%), $28.97 million in FY2022 (-25.2%) and $38.73 million in FY2021 (+28.5%).
  • Quarterly Research & Development has run from a low of $4.22 million in Q3 2025 to a high of $12.8 million in Q4 2021 over five years.
  • On a year-over-year basis, Research & Development has declined in each of the last five quarters, with an average decline of 6.0% over the last eight quarters.
  • The strongest year-over-year quarter for Research & Development in the past five years was Q4 2021, with growth of 38.5%; the weakest was Q3 2025, with a decline of 52.8%.
  • According to Business Quant data, Research & Development for the three prior quarters was $9.56 million (Q1 2026), $6.71 million (Q4 2025) and $4.22 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 3.65 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.34 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 9.74 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -2.85 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -4.05 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 1.87 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 1.76 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 2.81 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 993.80 Mn
10 Abeona Therapeutics 302.73 Mn -411.23 Mn 7.20 Mn 5.02 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.02 Mn
Mar 31, 2026 9.56 Mn
Dec 31, 2025 6.71 Mn
Sep 30, 2025 4.22 Mn
Jun 30, 2025 5.94 Mn
Mar 31, 2025 9.94 Mn
Dec 31, 2024 8.99 Mn
Sep 30, 2024 8.94 Mn
Jun 30, 2024 9.22 Mn
Mar 31, 2024 7.21 Mn
Dec 31, 2023 7.38 Mn
Sep 30, 2023 7.15 Mn
Jun 30, 2023 8.52 Mn
Mar 31, 2023 8.04 Mn
Dec 31, 2022 6.27 Mn
Sep 30, 2022 5.49 Mn
Jun 30, 2022 6.66 Mn
Mar 31, 2022 10.55 Mn
Dec 31, 2021 12.80 Mn
Sep 30, 2021 9.06 Mn
API Access

Abeona Therapeutics Research & Development API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=research-and-development&ticker=ABEO&period=max&api_key=YOUR_API_KEY